Addiction stigma

Addiction stigma in Dopesick is more than a label attached to drug use: it shapes whether families disclose what is happening, whether communities respond, and whether people seeking recovery are welcomed into support. The book follows its effects across suburban Virginia, from early reporting met with family silence to the isolation of parents and the rejection of medication-assisted treatment in some recovery settings. These scenes sit alongside medical and commercial systems that helped frame addiction as unlikely, leaving shame to fall heavily on people and families already navigating a fragmented response.

Shame, Secrecy, and Public Disclosure

When reporting on heroin’s spread into the suburbs of Roanoke began in 2012, many families were too ashamed to speak on the record. By the time the book was completed five years later, nearly everyone approached agreed to be identified, although some still feared that going public could endanger their work or safety. That change marks a movement from private suffering toward public testimony, but it does not mean the risks of disclosure had disappeared.

The account also describes how little connective support was available to parents at the beginning of that period. In 2012, there were no Facebook groups linking families across Virginia to exchange rehabilitation information, coping strategies, or practical help. Without those networks, a family could experience addiction as a private crisis rather than recognize it as part of a wider regional problem. Shame therefore operated not only as a painful feeling but as a condition that made shared knowledge and mutual support harder to find.

At a Families Anonymous meeting in a Lutheran church near Hidden Valley, two mothers met while seeking peer support for their opioid-addicted sons. Their encounter brings stigma into the space between households and institutions: families struggled to keep loved ones alive while criminal justice and health care systems left substantial gaps between them. The book also notes that secrecy could protect people and organizations profiting from those gaps. The meeting offered a point of contact, but the larger landscape remained one in which relatives and people with addiction had to manage the consequences of disconnected systems.

Medical Narratives and the Meaning of Addiction

The book sets family shame against the confident claims used to promote prescription opioids. Purdue Pharma presented OxyContin as safe when taken as prescribed, and its representative, David Haddox, described addiction as exceptionally rare in company training. Those claims form part of the context in which addiction could be treated as an unusual failure rather than a foreseeable danger. The evidence does not make every later instance of stigma a direct result of corporate messaging; it does show that public assurances of low risk coexisted with families’ difficulty speaking about addiction and its consequences.

That assurance gained force during a broader change in pain care. As hospitals and accreditation bodies elevated pain assessment, the Joint Commission adopted mandatory standards for pain assessment and treatment. Purdue Pharma saw an opportunity to position itself as an expert in helping hospitals meet those requirements, planning branded materials that included wall charts, binders, and pens. Yet the apparent precision of pain scales did not settle what adequate relief meant. The book notes that a subjective rating could make very different experiences look equivalent, while reliance on pain scales was associated with increased opioid prescribing and abuse. This tension matters to the subject of stigma: the systems that formalized pain treatment offered measurable procedures, while addiction and its risks remained subject to minimization and blame.

The wider promotion environment was also changing. After federal rules on pharmaceutical advertising loosened, drug advertising grew rapidly, and companies increasingly used free promotional items with doctors. Purdue targeted physicians already prescribing competing painkillers, with more sales visits directed toward those considered especially likely to prescribe. These details describe a commercial and medical setting that normalized opioid use; they do not erase the reality of addiction or establish that stigma alone explains the crisis. Instead, they expose an imbalance in how the problem was framed: prescribing was actively encouraged, while the people and families dealing with addiction often faced silence and shame.

Stigma Across Communities

The book’s accounts resist the idea that addiction belonged only to a visibly marginalized population. In 2006, Clifton “Lite” Lee brought heroin into Roanoke’s suburban networks; two teenagers caught selling for him led investigators to evidence involving dozens of other young people, many attending Hidden Valley High School in one of the county’s wealthiest neighborhoods. The episode does not mean stigma affected every community identically. It does show why assumptions that affluence or social respectability could keep addiction at a distance were inadequate.

A similar contradiction appears in the account of parents who believed that an affluent school zone would offer their children protection. Janine Underwood later spoke to school and county officials about what was happening locally. She reported meeting silence in the room; the school board declined to support the proposed program, and the county provided its usual $2,000. Her experience shows how stigma and community denial can persist even when a parent brings the issue directly to public authorities. In nearby Hidden Valley and Cave Spring, calls about heroin use were frequent, and police data indicated a particularly severe problem in those communities. The distance between the documented problem and the muted official response is part of the book’s account of how shame becomes public inaction.

Treatment, Exclusion, and the Cost of Silence

Stigma also appears within settings intended to support recovery. Tess Henry had attended twelve-step meetings before, but felt judged for taking buprenorphine. Some participants regarded medication-assisted treatment as incompatible with being drug-free or as merely substituting one opioid for another. Although Narcotics Anonymous officially accepted medication-assisted treatment, members asked to sponsor or mentor Tess declined. The distinction between formal policy and people’s responses mattered: a treatment approach could be accepted in principle while the person relying on it remained without the peer support she sought.

The book follows this exclusion over the two years in which Tess’s experience was observed. Her difficulty was not simply whether a meeting existed, but whether she could participate without having her medication treated as evidence against her recovery. That conflict placed recovery inside competing definitions of legitimacy: one emphasizing medication-supported care, another treating medication as a reason to withhold recognition. The account presents this as a cultural divide between public-health approaches and criminal-justice perspectives in Appalachian communities, not as a disagreement resolved by official policy alone.

In its acknowledgments, the author singles out Patricia Mehrmann for allowing extensive access to her life and for confronting the stigma of addiction with unusual openness. That recognition returns the book to the importance of testimony. The families who first hesitated to be named, the mothers who sought one another’s company, the parent whose appeal met silence, and the person whose treatment drew rejection all show different costs of stigma. Speaking publicly can make hidden suffering visible, but the book’s examples also show that visibility alone does not guarantee institutional support or acceptance in recovery.